In this study we tested a hypothesis that B-cell lymphomas secrete previously unrecognized molecules that disrupt HLA class II antigen presentation, rendering tumor cells invisible to CD4+ T cells and fostering an immunosuppressive niche. This evidence concerns the gene CD4 and neoplasm.